ABSTRACT
Receptors in Multiple Myeloma and Other Hematologic Malignancies.................... 105
4.5.1 Stem Cell Transplantation and Tumor Angiogenesis ..................................... 105
4.5.2 Therapeutic Approaches to Target VEGF .....................................................105
4.5.3 Anti-VEGF Antibody (Bevacizumab; Avastin)..............................................106
4.5.4 VEGF-Trap .................................................................................................... 107
